The association of cycling with all-cause, cardiovascular and cancer mortality: findings from the population-based EPIC-Norfolk cohort by Sahlqvist, Shannon et al.
		
 
 
 
 
 
 
 
 
 
This is the published version 
 
Sahlqvist, Shannon, Goodman, Anna, Simmons, Rebecca K., Khaw, Kay-Tee, 
Cavill, Nick, Foster, Charlie, Luben, Robert, Wareham, Nicholas J. and Ogilvie, 
David 2013, The association of cycling with all-cause, cardiovascular and cancer 
mortality: findings from the population-based EPIC-Norfolk cohort, BMJ Open, 
vol. 3, no. 11, pp. 1-10. 
 
 
 
 
 
 
 
Available from Deakin Research Online 
 
http://hdl.handle.net/10536/DRO/DU:30059657	
	
	
	
	
	
	
	 	
Reproduced with the kind permission of the copyright owner 
	
 
 
 
 
 
 
Copyright: 2013, BMJ Group 
The association of cycling with all-cause,
cardiovascular and cancer mortality:
ﬁndings from the population-based
EPIC-Norfolk cohort
Shannon Sahlqvist,1,2,3 Anna Goodman,2,4 Rebecca K Simmons,1 Kay-Tee Khaw,5
Nick Cavill,6,7 Charlie Foster,7 Robert Luben,8 Nicholas J Wareham,1,2
David Ogilvie1,2
To cite: Sahlqvist S,
Goodman A, Simmons RK, et
al. The association of cycling
with all-cause, cardiovascular
and cancer mortality: findings
from the population-based
EPIC-Norfolk cohort. BMJ
Open 2013;3:e003797.
doi:10.1136/bmjopen-2013-
003797
▸ Prepublication history and
additional material for this
paper is available online. To
view these files please visit
the journal online
(http://dx.doi.org/10.1136/
bmjopen-2013-003797).
Received 13 August 2013
Revised 9 October 2013
Accepted 10 October 2013
For numbered affiliations see
end of article.
Correspondence to
Dr Shannon Sahlqvist;
shannon.sahlqvist@deakin.
edu.au
ABSTRACT
Objectives: To investigate associations between
modest levels of total and domain-specific (commuting,
other utility, recreational) cycling and mortality from all
causes, cardiovascular disease and cancer.
Design: Population-based cohort study (European
Prospective Investigation into Cancer and Nutrition
study-Norfolk).
Setting: Participants were recruited from general
practices in the east of England and attended health
examinations between 1993 and 1997 and again
between 1998 and 2000. At the first health assessment,
participants reported their average weekly duration of
cycling for all purposes using a simple measure of
physical activity. At the second health assessment,
participants reported a more detailed breakdown of their
weekly cycling behaviour using the EPAQ2 physical
activity questionnaire.
Participants: Adults aged 40–79 years at the first
health assessment.
Primary outcome measure: All participants were
followed for mortality (all-cause, cardiovascular and
cancer) until March 2011.
Results: There were 22 450 participants with complete
data at the first health assessment, of whom 4398 died
during follow-up; and 13 346 participants with
complete data at the second health assessment, of
whom 1670 died during follow-up. Preliminary analyses
using exposure data from the first health assessment
showed that cycling for at least 60 min/week in total was
associated with a 9% reduced risk of all-cause mortality
(adjusted HR 0.91, 95% CI 0.84 to 0.99). Using the
more precise measures of cycling available from the
second health assessment, all types of cycling were
associated with greater total moderate-to-vigorous
physical activity; however, there was little evidence of an
association between overall or domain-specific cycling
and mortality.
Conclusions: Cycling, in particular for utility purposes,
was associated with greater moderate-to-vigorous and
total physical activity. While this study provides tentative
evidence that modest levels of cycling may reduce the
risk of mortality, further research is required to confirm
how much cycling is sufficient to induce health benefits.
INTRODUCTION
Promoting cycling as an alternative to
motorised transport would result in reduced
carbon emissions, trafﬁc congestion and
noise pollution while providing people with
an opportunity to integrate regular physical
activity into their lives.1 2 As such, there is
increasing policy interest in quantifying the
health beneﬁts of cycling so that they can be
accurately modelled in the economic
appraisal of proposed policies and interven-
tions in the transport and health sectors.3 4
One such tool developed by the WHO
(Health Economic Assessment Tool; HEAT)
estimates the economic value of a reduction
in mortality as a consequence of population
increases in cycling.5 It does so by assuming
a linear dose–response relationship between
cycling and mortality and that any increase
in cycling is in addition to other physical
activity.
HEAT model estimates are dependent on
the use of a relative risk estimate from a
single study of Danish adults. The study
reported a 28% reduction in all-cause mor-
tality in adults who cycled to and from work
Strengths and limitations of this study
▪ The strengths of this study include its prospect-
ive design, the inclusion of a large heteroge-
neous population of men and women and the
long follow-up.
▪ Further, this study used detailed measures of
cycling and overall physical activity to examine
associations between the various domains of
cycling and mortality.
▪ Owing to the low average levels of cycling, we
were not able to examine the specific effects of a
higher ‘dose’ of cycling, and the analyses were
underpowered to examine sex differences in the
associations between cycling and mortality.
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compared with those who did not, even after controlling
for other physical activity.6 Similarly, an inverse associ-
ation between transport (utility) cycling more generally
and all-cause and cancer mortality has been reported in
a cohort of Chinese women.7 These ﬁndings are likely
to reﬂect, in part, the fact that utility cycling translates
into greater overall physical activity.8 9
While these studies suggest substantial health beneﬁt
associated with utility cycling, an examination of the
beneﬁts of recreational cycling would also be valuable to
enable more informed policy recommendations on
which type of cycling to promote.
Furthermore, it is possible that the ﬁndings from
these studies reﬂect, at least to some extent, residual
confounding from ‘other’ physical activity. In particular,
the Danish study controlled for recreational physical
activity using responses to a single item which asked par-
ticipants to select from one of four options ranging from
‘you are almost entirely sedentary or perform light phys-
ical activity less than 2 h/week’ to ‘you perform highly
vigorous physical activity more than 4 h/week or regular
exercise or competitive sports several times per week’.6
The extent to which responses to this item were inde-
pendent of those regarding commuter cycling was not
reported.
In addition, in the two prior studies which reported
associations between utility cycling and mortality, the
time spent cycling for transport in the exposed groups
was substantial, reﬂecting the relatively high levels of
cycling in those countries. For example, in the Danish
study, those who commuted by bike spent an average of
180 min/week doing so.6 In the study of Chinese
women, 19% cycled for up to 3.4 metabolic equivalents
(MET) h/day while a further 5% cycled for greater than
3.5 MET h/day, equivalent to approximately 350 min/
week.7 Few studies have examined associations between
cycling and mortality in populations such as that of the
UK, which have a low prevalence of utility cycling by
international standards. One previous study of adults in
the European Prospective Investigation into Cancer and
Nutrition study (EPIC)-Norfolk cohort found no signiﬁ-
cant association between commuter cycling and either
cardiovascular or all-cause mortality.10 These null ﬁnd-
ings may partly reﬂect the cut points used to deﬁne
cycling categories: the cut point for the highest category
was 30 min/week, which may be an insufﬁcient ‘dose’ to
induce health beneﬁts. It is also possible that the rela-
tively short duration of follow-up (7 years) and the small
number of deaths in the cohort limited the power of the
study to detect effects.
Building on these previous analyses of EPIC-Norfolk
cohort data, this paper aims to investigate more compre-
hensively the mortality beneﬁts of cycling. First, we use a
simple pragmatic measure of physical activity to examine
associations between total cycling and all-cause, cardio-
vascular and cancer mortality over 15 years. Second,
using a more detailed, disaggregate measure of physical
activity which provides more accurate estimates of
domain-speciﬁc cycling (commuting, all utility and rec-
reational) for a subset of our sample, we explore
whether this association is driven by particular domains
of cycling (eg, utility vs recreational). Finally, to help
explain any associations between domain-speciﬁc cycling
and mortality, we examine associations between these
domains of cycling and total physical activity.
METHODS
Study design and participants
This study uses data from the EPIC-Norfolk cohort, part
of the 10-country collaborative EPIC. Between 1993 and
1997, 25 633 adults aged 40–79 years were recruited
from general practices in the county of Norfolk in the
east of England and attended a health examination. As
part of this examination, participants completed a short
physical activity questionnaire which asked about time
spent walking and cycling for all purposes and time
spent in other exercise.11 Between January 1998 and
October 2000, 15 519 (61%) of the original cohort
attended a second health assessment, completing a
more detailed questionnaire on recreational, occupa-
tional, utility and household physical activity (EPAQ2).12
Data from the ﬁrst health assessment were used to
examine the association between total cycling and cardio-
vascular disease, while data from the second health assess-
ment were used to examine the association between the
domains of cycling and cardiovascular disease. Full
details of the study are reported elsewhere.13
Of the participants in the ﬁrst health assessment, we
excluded those with self-reported cardiovascular disease
(n=1102) or cancer (n=1327) and those with missing
data (n=784) leaving 22 450 for analysis.
Similarly, of those who returned for the second health
assessment, we excluded those with self-reported cardio-
vascular disease (n=772) or cancer (n=1115) and those
with missing data (n=286), leaving 13 346 for analysis.
All participants were followed up for mortality to 31
March 2011 (mean 15.3 years (SD=3.3) from ﬁrst health
assessment, mean 11.5 years (SD=2.0) from second
health assessment).
Health assessments
At both health assessments, participants reported their
level of education (categorised as no formal qualiﬁca-
tion; GCSE or equivalent, that is, examinations normally
taken at age 16; ‘A’ level or equivalent, that is, examina-
tions normally taken at age 18; university degree or
equivalent), paid employment status (yes, no), social
class (categorised as professional, managerial/technical
job, skilled/partially skilled labour, unskilled labour),
smoking status (current, former, never), antihyperten-
sive medication (yes, no), medication for dyslipidaemia
(yes, no) and family history of cancer and cardiovascular
disease (yes, no). History of myocardial infarction,
stroke and cancer were also reported. Total energy
intake (kJ/day) and alcohol consumption (units/week)
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were derived from a validated 130-item semiquantitative
food-frequency questionnaire.14
Measurement of physical activity at first health
assessment
Physical activity was assessed by asking participants to
report, separately for winter and summer, the weekly
time (in hours) spent walking and cycling (separately)
to work and during leisure, and in other exercise.11
Total cycling was calculated as the average weekly time
spent in winter and summer (min/week; (see online
supplementary appendix, part 1).
Measurement of physical activity at second health
assessment
Physical activity, including cycling, was assessed with the
validated and reliable EPAQ2 questionnaire, which asks
participants to recall their physical activity behaviour
across the domains of household, work, recreation and
commuting, over the past year.12 Energy expenditure
[MET h/week] was calculated using the physical activity
compendium.15 Following standard EPAQ2 data
reduction rules, we calculated four speciﬁc cycling mea-
sures explained in detail in table 1. In addition, total
moderate-to-vigorous physical activity was calculated as
the sum of all moderate and vigorous physical activity
across all domains (home, work, recreation and com-
muting; MET h/week) and recreational physical activity
was computed as the sum of all moderate and vigorous
activity done during recreation speciﬁcally (MET h/
week). A copy of the questionnaire can be found at:
http://www.srl.cam.ac.uk/epic/questionnaires/epaq2/
epaq2.pdf.
Cycling exposure
Given the highly skewed nature of the cycling data and
to allow for comparisons with previous studies, we
created three categories of cycling exposure: 0, 1–59 and
≥60 min/week. These represent levels of cycling which
we believe are realistic to achieve in countries such as
the UK, which currently have low levels of utility cycling.
For our measures of utility cycling from the second
health assessment, these categories are equivalent to: 0;
0.01–9.99 and ≥10 miles/week.
Table 1 Cycling exposure measures calculated from the EPAQ2 questionnaire administered at the second health
assessment
Exposure Calculation
Commuter cycling Respondents were asked how frequently they normally travelled to work by car, public transport,
bike or on foot (response options were ‘always’, ‘usually’, ‘occasionally’ or ‘never/rarely’).
Responses were converted to fractions (always=1, usually=0.75, occasionally=0.25, never/
rarely=0). Participants reported the distance between home and work and the average number of
times per week they made this journey (multiplied by two to account for the return journey). When
cycling was the only mode selected, the total weekly distance cycled was calculated by
multiplying the distance from home to work by the number of journeys made. When cycling was
selected alongside other modes, the distance cycled was weighted according to the frequency of
cycling relative to the frequency of the other modes reported. For example, if a respondent
selected ‘always’ for cycling and driving, it was assumed that cycling accounted for 10%, and
driving for 90% of the distance travelled. The total number of journeys was then multiplied by the
weighted distance travelled (miles/week)
Non-commuting utility
cycling
Respondents were asked to recall the average number of journeys they made by bicycle to get
about apart from going to work for each of the following distances: ‘less than 0.5 miles’, ‘0.5 mile–
1.5 miles’, ‘1.5–2.5 miles’, ‘2.5–3.5 miles’, ‘3.5–5.5 miles’, and ‘more than 5.5 miles’. The total
weekly distance travelled was computed by multiplying the reported number of trips by the
midpoint value of each distance category (assumed to be 0.25 for <0.5 mile and 6 for >5.5 miles).
These values were then summed to provide a measure of distance travelled (miles/week)
All utility cycling Distance travelled for non-commuting utility cycling was added to the distance travelled for
commuting cycling to derive a measure of total utility cycling (miles/week)
Recreational cycling Respondents reported the average time spent ‘cycling for pleasure’ per session and the
frequency of such sessions: ‘none’, ‘less than once a month’, ‘once a month’, ‘2–3 times a
month’, ‘once a week’, ‘2–3 times a week’, ‘4–5 times a week’, or ‘everyday’. The average weekly
cycling duration was computed by converting the frequency into a weekly numerical value (eg,
0.5/52 for ‘less than once a month’ and (2.5×12)/52 for ‘2–3 times per month’). The time spent
cycling (min/week) was computed by multiplying the average session duration by the average
weekly frequency
Total cycling To enable a measure of total cycling to be derived and to allow for comparisons with previous
studies, the distance travelled for utility cycling was converted into an estimated duration. Based
on self-report data from a recent study of UK adults, we assumed an average cycling speed of
10 miles/h.27 A measure of total time spent cycling (min/week) was derived by summing time
spent in commuting, other utility and recreational cycling
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Mortality outcomes
All EPIC-Norfolk participants were ﬂagged for death cer-
tiﬁcation with the UK Ofﬁce of National Statistics
(ONS). Trained nosologists coded death certiﬁcates
according to the ICD-9 or ICD-10 codes. Cardiovascular
death was deﬁned as ICD 410–448 (ICD 9) or ICD I10–
I79 (ICD 10) as underlying cause of death, which
comprises coronary heart disease (410–414 (ICD 9) or
I20–I25 (ICD 10)), stroke (430–438 (ICD 9) or I60–I69
(ICD 10)), cardiac failure (428 (ICD 9) or I50 (ICD
10)) and other vascular causes. Cancer death was
deﬁned as ICD 140–208 (ICD9) or ICD C00–C97
(ICD10) as the underlying cause.
Statistical analysis
We used exposure data from the ﬁrst health assessment
to examine associations between total cycling and all-
cause, cardiovascular and cancer mortality. Exposure
data from the second health assessment were used to
explore associations between total and domain-speciﬁc
cycling and mortality and overall physical activity. First,
using data collected from the ﬁrst health assessment, we
examined preliminary associations between total cycling
and all-cause, cardiovascular and cancer morality by
ﬁtting Cox proportional hazard regression models to
estimate HRs and 95% CIs. We ﬁrst adjusted for sex,
age, education level and social class (model A) and then
further adjusted for smoking status, family history of car-
diovascular disease or cancer, as well as time spent
walking and in other exercise. As sensitivity analyses, we
ran a further two models. In the ﬁrst model, we adjusted
for weekly alcohol consumption and calorie intake; 4%
(n=912) of participants had missing data for these vari-
ables. In the second, we further adjusted for medication
(hypertension and dyslipidaemia) and type 2 diabetes as
we thought it possible that they could be mediating vari-
ables on the causal pathway between cycling and mortal-
ity. The results of these subgroup analyses did not differ
substantially from those of model B and are not pre-
sented. Models were also run after excluding partici-
pants who died within 2 years of follow-up (n=181) to
minimise the potential effect of reverse causality. This
made no substantive differences to the ﬁndings (data
not presented).
We then examined the associations between the
domains of cycling and mortality, again by ﬁtting Cox
proportional hazard regression models. Equivalent
models to those described above were run except that
model B also controlled for all other physical activity
energy expenditure (calculated as the sum of all energy
expenditure in all domains of physical activity minus
that of the respective cycling behaviour). To account for
the potentially conservative estimates of commuting
cycling undertaken when cycling was selected alongside
other modes (see table 1), by way of sensitivity analysis
we applied an alternative assumption that commuter
cycling was done for 30% (rather than 10%) of these
journeys. The ﬁndings remained largely unchanged
when using these new estimates. Again, our results were
substantively unchanged after adjusting for weekly
alcohol consumption and calorie intake, or after exclud-
ing the 102 participants who died within 2 years of
follow-up (data not presented).
For all models, the proportional hazard assumption
was veriﬁed using the Schoenfeld residuals and
Kaplan-Meier plots for all three outcomes. For all
models, we also present p values for linear trend, calcu-
lated by entering the domains of cycling as continuous
rather than categorical variables.
To examine whether any observed associations
between cycling and mortality could be explained by dif-
ferences in overall levels of physical activity, we examined
associations between the domains of cycling and physical
activity (total leisure-time, total moderate-to-vigorous
across all domains, and total light, moderate and vigor-
ous across all domains) by ﬁtting linear regression
models with time spent cycling (total and subdomains)
as the exposure variables and time spent in (A) recre-
ational and (B) total moderate-to-vigorous physical activ-
ity (MET h/week) as the outcome variables controlling
for sex, age, social class and highest level of education.
All analyses were conducted using STATA, V.12.0 (Stata
Corp, Texas, USA).
RESULTS
Participant characteristics
At the ﬁrst health assessment, participants had a mean
age of 58 years (SD=19) and just over half were women
(55%). Twenty four per cent of the participants reported
cycling for a mean of 165 min/week (SD=246).
Sociodemographic characteristics of the cohort by cycling
status (yes, no) are described in table 2 (for further details
of the baseline characteristics of the sample, see online
supplementary appendix, part 2, table A1). Respondents
who reported any cycling were, on average, younger and
more likely to be men. Respondents with no formal qualiﬁ-
cation were also more likely to cycle compared with
respondents with GCSE-level qualiﬁcations, while those in
skilled or unskilled labour were more likely to cycle than
professionals.
By the second health assessment, participants had a
mean age of 62 (SD 9) years; just over half were women
(57%). Thirty per cent (n=4030) reported any cycling.
Of those who cycled, 62% (n=2808) reported cycling for
recreation and 72% (n=3269) reported cycling for utility
purposes with 26% (n=862) of these reporting commut-
ing cycling. The average cyclist spent 83 min/week
cycling. Those who commuted by bicycle spent an
average of 61 min/week doing so, while those who
cycled for recreation spent an average of 58 min/week
doing so. Again, men and those who were younger were
more likely to cycle. In addition to the sociodemo-
graphic associations observed in data from the ﬁrst
health assessment, respondents working in a manager-
ial/technical position were less likely to cycle than
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professionals. Employment status also showed a strong
association with cycling, probably reﬂecting the fact that
commuting was included in the measure of cycling (see
online supplementary appendix, part 2, table A2).
Total cycling (first health assessment) and mortality
In total, 4398 (20%) participants died during 3 425 498
person-years of follow-up (table 3). There were 1379
(6.1%) cardiovascular deaths and 1639 (7.3%) cancer
deaths (see online supplementary appendix, Part 2,
table A3). Risk of death was associated with being male
older and having a lower level of education and social
class.
Cycling for at least 60 min/week was associated with a
9% reduction in all-cause mortality after controlling for
potential confounders (HR 0.91, 95% CI 0.84 to 0.99;
table 3). In the minimally adjusted model, cycling for at
least 60 min/week was associated with a 19% reduction
in cardiovascular mortality (HR 0.81, 95% CI 0.69 to
0.95); however, this was no longer signiﬁcant after con-
trolling for potential confounders including time spent
walking and in other exercise. Cycling was not associated
with cancer mortality.
Domains of cycling (second health assessment)
and mortality
In total, 1670 (12.5%) individuals died during 149 072
person-years of follow-up. There were 485 (3.6%) cardio-
vascular deaths and 700 (5.2%) cancer deaths. Again,
mortality rates were higher among men and older parti-
cipants (data not shown). There were no signiﬁcant asso-
ciations between commuting cycling and all-cause,
cardiovascular or cancer mortality in either the
minimally adjusted (A) or the additionally adjusted (B)
models (table 4). For all-cause and cancer mortality,
however, there was a suggestion of a dose–response rela-
tionship between the distance cycled and risk of death
whereby the lowest HRs were observed for the highest
levels of commuting cycling, albeit not reaching statis-
tical signiﬁcance. There was no association between all
utility cycling and all-cause, cardiovascular or cancer
mortality in either the minimally adjusted (A) or the
additionally adjusted (B) models. In minimally adjusted
models, recreational cycling for less than 60 min/week
was associated with a 19% (95% CI 0.66 to 0.99) reduc-
tion in risk. Further adjustment attenuated the effect.
There were no signiﬁcant associations between total
cycling and mortality.
Association between domains of cycling and total physical
activity (second health assessment)
Total and domain-speciﬁc cycling was associated with
greater levels of physical activity in an approximately
dose–response relationship (table 5). All utility, recre-
ation and total, but not commuting, cycling was asso-
ciated with greater recreational physical activity.
Importantly, however, commuting cycling was not
inversely associated with recreational physical activity,
suggesting that adults were not cycling to and from work
to compensate for a lack of recreational physical activity.
The association between cycling and recreational phys-
ical activity was strongest for recreational cycling; those
who spent 1–59 min/week cycling for pleasure partici-
pated in an additional 3 MET h/day of recreational
physical activity (equivalent to approximately 36 min/
day of moderate intensity physical activity).
Table 2 Descriptive characteristics of sample (N (%) at first health assessment (n=22 450) by cycling (yes, no)
Characteristic 0 min/week: N (column %) ≥1 min/week: N (column %) OR for any cycling (95%CI)*
Sex
Male 3880 (66.9) 1920 (72.0) 1.0
Female 5436 (33.1) 2110 (28.0) 0.92 (0.86, 0.98)
Age (years)
40–55 2096 (58.1) 1498 (41.7) 1.0
50–65 3105 (67.4) 1473 (32.2) 0.72 (0.67, 0.78)
≥65 4115 (79.4) 1059 (20.5) 0.44 (0.40, 0.49)
Education level
Degree or equivalent 1280 (65.6) 670 (34.4) 1.0
‘A’ level or equivalent 3867 (69.2) 1719 (30.8) 0.91 (0.81, 1.02)
GCSE or equivalent 1054 (71.0) 431 (29.0) 1.02 (0.95, 1.11)
No formal qualification 3115 (72.09) 1210 (28.0) 1.29 (1.15, 1.44)
Social class
Professional 665 (66.4) 336 (33.6) 1.0
Managerial/technical 5269 (71.8) 2071 (28.2) 0.90 (0.79, 1.02)
Skilled/partially skilled labour 3078 (67.7) 1469 (32.3) 1.15 (1.00, 1.31)
Unskilled labour 304 (66.4) 154 (33.6) 1.36 (1.08, 1.64)
Paid employment
No 8578 (81.0) 2080 (19.0) 1.0
Yes 8365 (72.5) 2127 (27.2) 1.05 (0.97, 1.14)
*Adjusted for all other variables in the table.
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All domains of cycling showed signiﬁcant dose-
response relationships with total moderate-to-vigorous
physical activity, although the association was
strongest for commuting cycling. Those who cycled for
≥60 min/week spent an additional 7.9 MET h/day in
moderate-to-vigorous physical activity (equivalent to
94.8 min/day of moderate intensity physical activity)
compared with those who did not.
DISCUSSION
We used data from a large population-based cohort to
examine the associations between total and domain-
speciﬁc cycling and mortality. Across all domains,
cyclists were more likely to be younger and men, a
ﬁnding that is consistent with previous studies con-
ducted in countries that have low rates of utility
cycling16–18 but different from the pattern in a number
of other European countries where men and women,
and the young and old, are equally likely to cycle.19 An
important ﬁnding was that cycling, in particular com-
muting cycling, was associated with participation in
greater levels of total physical activity. These ﬁndings
support an increasing body of work which shows that
active travel is done in addition to, rather than instead
of, recreational physical activity.8 9 20 21 Given the time
people spend travelling, and the fact that a shift from
motorised to active travel may result in environmental
and economic beneﬁt, encouraging participation in
cycling appears a valuable way to increase participation
in overall physical activity.
Using exposure data from the ﬁrst health assessment,
cycling for at least 60 min/week in total was associated
with a 9% reduction in risk of all-cause mortality but was
not associated with reductions in risk of cardiovascular
or cancer mortality. In the absence of any directly com-
parable data on total cycling from other studies, these
ﬁndings provide tentative evidence that modest ‘doses’
of cycling may be associated with a reduction in mortal-
ity risk. They are also broadly consistent with the ﬁnd-
ings of the Danish study in which a reduction in
mortality risk (28%) was associated with an average
quantity of cycling that was three times higher
(180 min/week).6
That being said, when using more precise measures of
cycling, we found no signiﬁcant associations between
total or domain-speciﬁc cycling and mortality. On the
one hand, these differences may reﬂect the more
precise measures of physical activity used in the second
health assessment, which may have not only enabled
more accurate categorisation of cycling exposure, but
also reduced measurement error regarding the con-
founding effect of ‘other’ physical activity. On the other
hand, they could reﬂect a lack of power in analyses of
the second health assessment data, which included
fewer participants and had a shorter follow-up period.
Despite 5 additional years of follow-up and the exam-
ination of a higher ‘dose’ of cycling, our null ﬁndings
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Table 4 Prospective association over 11.5 years between cycling (total and domain specific) and mortality (all-cause, cardiovascular and cancer) in 13 346 participants
FU years
Mean (SD)
All-cause mortality Cardiovascular mortality Cancer mortality
Events N (%) HR (95%CI) Events N (%) HR (95%CI) Events N (%) HR (95%CI)
Model A† Model B‡ Model A† Model B‡ Model A† Model B‡
Commuting
0 miles/week (0 min/
week)
11.1 (2.0) 1630 (13.1) 1 1 474 (3.8) 1 1 679 (5.4) 1 1
0.01–9.99 miles/week
(1–59 min/week)
11.5 (1.6) 29 (4.9) 0.87
(0.60, 1.26)
0.96
(0.66, 1.39)
9 (1.5) 1.09
(0.56, 2.13)
1.23
(0.63, 2.40)
16 (2.7) 0.90
(0.55, 1.49)
0.95
(0.57, 1.57)
≥10 miles/week
(≥60 min/week)
11.5 (1.4) 11 (4.0) 0.80
(0.44, 1.46)
0.91
(0.50, 1.65)
2 (0.7) 0.61
(0.15, 2.47)
0.71
(0.18, 2.90)
5 (1.8) 0.66
(0.27, 1.59)
0.68
(0.28, 1.66)
p for linear trend 0.42 0.74 1.00 0.72 0.28 0.34
All utility
0 miles/week 0 min/
week)
11.1 (2.0) 1383 (13.2) 1 1 392 (3.8) 1 1 580 (5.5) 1 1
0.01–9.99 miles/week
(1–59 min/week)
11.6 (1.8) 233 (10.4) 0.90
(0.78, 1.04)
0.95
(0.83, 1.09)
75 (3.4) 1.04
(0.81, 1.34)
1.10
(0.85, 1.41)
97 (4.3) 0.85
(0.69, 1.06)
0.90
(0.72, 1.11)
≥10 miles/week
(≥60 min/week)
11.4 (1.8) 54 (8.4) 1.01
(0.77, 1.33)
1.10
(0.83, 1.44)
18 (2.8) 1.30
(0.81, 2.10)
1.44
(0.89, 2.31)
23 (3.6) 0.89
(0.58, 1.35)
0.92
(0.61, 1.41)
p for linear trend 0.71 0.33 0.81 0.52 0.94 0.89
Recreational
0 min/week 11.1 (2.1) 1483 (13.7) 1 1 438 (4.0) 1 1 608 (5.6) 1 1
1–59 min/week 11.4 (1.5) 104 (5.9) 0.81
(0.66, 0.99)*
0.87
(0.69, 1.04)
25 (1.4) 0.72
(0.48, 1.09)
0.75
(0.50, 1.13)
56 (3.2) 0.90
(0.68, 1.19)
0.95
(0.71, 1.25)
≥60 min/week 11.3 (1.8) 83 (11.1) 1.13
(0.90, 1.41)
1.25
(0.99, 1.55)
22 (3.0) 1.07
(0.69, 1.65)
1.19
(0.77, 1.84)
36 (4.8) 1.06
(0.75, 1.49)
1.12
(0.80, 1.58)
p for linear trend 0.12 0.05 0.48 0.32 0.46 0.35
Total cycling
0 min/week 11.1 (2.1) 1308 (14.0) 1 1 379 (4.1) 1 1 540 (5.8) 1 1
1–59 min/week 11.5 (1.8) 236 (8.9) 0.87
(0.76, 1.00)*
0.90
(0.79, 1.04)
72 (2.7) 0.95
(0.74, 1.23)
0.99
(0.76, 1.23)
105 (4.0) 0.86
(0.70, 1.06)
0.90
(0.73, 1.11)
≥60 min/week 11.4 (1.7) 126 (9.2) 1.00
(0.83, 1.21)
1.11
(0.91, 1.32)
34 (2.5) 1.00
(0.70, 1.43)
1.10
(0.77, 1.57)
55 (4.0) 0.92
(0.69, 1.22)
0.98
(0.74, 1.30)
p for linear trend 0.08 0.26 0.36 0.18 0.81 0.51
*p<0.05, **p<0.01, ***p<0.001
†Adjusted for age, sex, education level and social class.
‡Further adjusted for smoking status, family history of cancer or cardiovascular disease, and all other physical activity.
FU, follow-up.
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relating to the mortality beneﬁts of commuting and
utility cycling in particular mirror those previously
reported in this cohort10 and are consistent with those
of previous studies of low-cycling populations in
Northern Ireland and France, which found no evidence
of a reduced risk of fatal or non-fatal myocardial infarc-
tion in men who reported any walking or cycling to
work compared with those who did not.22
They are, however, in contrast to the ﬁndings of the
studies of Danish6 and Chinese7 adults and of a
meta-analysis, which pooled evidence from eight studies
(from ﬁve independent populations) and found that
active commuting (walking and cycling) was associated
with an overall 11% reduction in the risk of cardiovascu-
lar outcomes.23 Importantly, the levels of commuting
cycling reported by participants in these previous studies
were substantial and in the meta-analysis, evidence of
protective effects was generally limited to higher levels
of active commuting.23 The high ‘doses’ of utility cycling
reported in previous studies are likely to be achieved
when cycling journeys are taken frequently and consist-
ently (eg, twice daily, 5 days/week). It is possible that fre-
quent short bursts of physical activity of this kind are
beneﬁcial to health in their own right, rather than
simply by contributing to greater levels of total physical
activity as we have shown. In support of this hypothesis,
studies have demonstrated that accumulated short bouts
of exercise over the day result in longer postexercise
reductions in blood pressure24 and lower plasma trigly-
cerides25 than one continuous session of exercise. There
is also some evidence that the intensity of cycling is
important. A study of Danish adults found a signiﬁcant
inverse association between cycling intensity and all-
cause and coronary heart disease mortality,26 and it may
be that participants in our study were not cycling at an
intensity sufﬁcient to result in health beneﬁt. It is also
possible that the differences reﬂect the fact that our
cohort was older than the Danish and Chinese cohorts.
To further elucidate the health beneﬁts of cycling and
reﬁne the use of tools such as HEAT that may be used to
Table 5 Associations between time spent cycling (total and subdomains; min/week) and physical activity (MET h/week) in
13 346 participants
Leisure time PA† (MET h/
week) Total MVPA‡ (MET h/week) Total PA§ (MET h/week)
N
Mean
(SD)
Regression
coefficient
(95% CI)¶ Mean (SD)
Regression
coefficient
(95% CI)¶ Mean (SD)
Regression
coefficient
(95% CI)¶
Commuter cycling
0 miles/week
(0 min/week)
12 484 39.4 (37.7) 0 61.9 (52.3) 0 82.1 (44.6) 0
0.01–9.99 miles/
week (1–59 min/
week)
587 35.3 (32.4) −1.6 (−4.7, 1.4) 82.4 (58.0) 12.2 (8.2, 16.2)*** 104.9 (46.8) 11.8 (8.3, 15.3)***
≥10 miles/week
(≥60 min/week)
275 42.9 (37.6) 1.9 (−2.5, 6.3) 116.6 (63.0) 35.3 (29.5, 41.0)*** 128.6 (49.2) 29.7 (24.7, 34.7)***
All utility cycling
0 miles/week
(0 min/week)
10 462 38.2 (37.1) 0 60.5 (51.7) 0 81.2 (44.2) 0
0.01–9.99 miles/
week (1–59 min/
week)
2237 42.9 (38.5) 3.7 (2.1, 5.4)*** 69.6 (55.4) 5.5 (3.3, 7.7)*** 89.2 (46.9) 4.4 (2.5, 6.3)***
≥10 miles/week
(≥60 min/week)
647 46.7 (39.3) 6.9 (3.9, 9.8)*** 99.0 (60.4) 25.0 (21.2, 28.9)*** 112.1 (50.0) 20.2 (16.9, 23.6)***
Leisure-time
cycling
0 min/week 10 843 37.3 (36.5) 0 60.0 (51.7) 0 80.5 (44.1) 0
1–59 min/week 1756 41.0 (35.4) 4.2 (2.3, 6.1)*** 73.8 (53.9) 4.7 (2.3, 7.2)*** 95.3 (45.3) 4.9 (2.8, 7.0)***
≥60 min/week 747 64.6 (46.6) 25.6 (22.9, 28.2)*** 98.0 (61.5) 27.4 (23.9, 31.0)*** 110.2 (52.5) 21.9 (18.9, 25.0)***
Total cycling
0 min/week 9316 37.2 (36.6) 0 58.5 (50.8) 0 79.3 (43.6) 0
1–59 min/week 2654 39.7 (35.8) 3.2 (1.6, 4.9)*** 67.0 (53.1) 2.9 (0.8, 5.0)* 88.3 (45.0) 2.6 (0.8, 4.4)*
≥60 min/week 1376 52.4 (43.6) 14.2 (12.2, 16.3)*** 94.4 (60.5) 24.1 (21.3, 26.8)*** 108.7 (50.7) 19.5 (17.1, 21.8)***
*p<.05, **p<0.01, ***p<.001.
†Computed as the sum of all moderate-to-vigorous leisure-time physical activity.
‡Computed as the sum of all moderate-to-vigorous physical activiy across all domains (leisure-time, household, work, commute).
§Computed as the sum of all light and moderate-to-vigorous physical activity across all domains (leisure-time, household, work, commute).
¶Adjusted for age, sex, education and social class.
MVPA, moderate-to-vigorous physical activity; PA, physical activity.
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inform policy in this area, future research should aim to
estimate the association between cycling and mortality
independent of other physical activity, measured with as
little error as possible; to extend such analyses to include
morbidity endpoints such as incident cardiovascular
disease and diabetes; and to clarify how much cycling is
sufﬁcient to induce health beneﬁts by quantifying the
mean quantity (and preferably intensity) of cycling in
each exposure category studied and describing the shape
of the dose–response relationship. In the meantime, our
results suggest that even modest ‘doses’ of cycling may
reduce mortality risk and do not suggest any evidence of
an adverse effect, thereby contributing to the growing
environmental, social and public health case for promot-
ing cycling in individuals and populations.
STRENGTHS AND LIMITATIONS
This is the ﬁrst study to examine independent associa-
tions between total and domain-speciﬁc cycling and
mortality. The other strengths of the study include its
prospective design, the inclusion of a large heteroge-
neous population of men and women and its long
follow-up. We adjusted our analyses of the second health
assessment data for all types of physical activity as well as
a range of potential demographic and behavioural con-
founders, which strengthens the inferences made.
Excluding participants with existing chronic disease and
those who died within two years of follow-up enabled us
to control for reverse causality. Given the population-
based recruitment from a large geographical area, we
believe that our ﬁndings are generalisable to
middle-aged and older-aged adults. There are, however,
a number of limitations. Cycling and total physical activ-
ity were assessed by self-report. The cycling exposure
variables, in particular utility cycling, were derived from
relatively crude measures and assumptions had to be
made about frequency of cycling, distance travelled and
average speed. Owing to the low average levels of
cycling, we were not able to examine the speciﬁc effects
of a high ‘dose’ of cycling and the analyses were under-
powered to examine sex differences in the associations
which have been previously documented.23
CONCLUSIONS
Building on previous research that demonstrated inverse
associations between high doses of utility cycling and
mortality, we used data from a large population-based
cohort to examine associations between more modest
levels of cycling and mortality. Cycling, in particular for
utility purposes, was associated with greater levels of
total and moderate-to-vigorous physical activity. This was
largely due to the fact that adults who cycled did not
participate in less leisure-time physical activity. Despite
these positive associations, there was little evidence that
cycling was associated with a reduction in mortality risk.
While our preliminary ﬁndings suggest that low levels of
cycling are associated with a reduced risk of mortality,
these ﬁndings were not replicated when using more
detailed measures of exposure, albeit in fewer partici-
pants who were followed up for a shorter period.
Nevertheless, cycling provides an opportunity to incorp-
orate frequent physical activity into activities of daily
living, and when done as a means to get from place to
place, it may also provide substantial environmental and
economic beneﬁts to society.
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